Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00285831 · ClinicalTrials.gov registry record
Mild Depression 2 Week Observational Study
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 36
- Enrollment target
NCT00285831: Completed study, sponsored by Stanford University.
NCT00285831 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00285831 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to assess whether the dysphoric-like depressive characteristics observed in people with epilepsy are unique to this patient population in comparison to three control groups: Mild Depression (enrolled at Stanford University), Migraine Headaches (enrolled at Long Island Jewish Medical Center), and Multiple Sclerosis (enrolled at Rush University Medical Center).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2005-12 |
| Est. Completion | 2009-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00285831
The ClinicalTrials.gov registry entry for NCT00285831 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00285831 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00285831 about?
NCT00285831 is a clinical study titled "Mild Depression 2 Week Observational Study". The purpose of this study is to assess whether the dysphoric-like depressive characteristics observed in people with epilepsy are unique to this patient population in comparison to three control groups: Mild Depression (enrolled at Stanford University), Migraine Headaches (enrolled at Long Island Je...
What is the current status of trial NCT00285831?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2005-12. Estimated completion is 2009-03.
Who is sponsoring clinical trial NCT00285831?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.